HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl Hörmann Selected Research

Asthma (Bronchial Asthma)

1/2017Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy.
1/2016Effect of TH2 cytokines and interferon gamma on beat frequency of human respiratory cilia.
4/2008Influence of interleukin-13 on beta-catenin levels in eosinophilic chronic rhinosinusitis cell culture.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl Hörmann Research Topics

Disease

25Neoplasms (Cancer)
07/2022 - 07/2002
21Squamous Cell Carcinoma of Head and Neck
05/2017 - 07/2002
9Obstructive Sleep Apnea
11/2021 - 09/2005
8Head and Neck Neoplasms (Head and Neck Cancer)
07/2022 - 07/2002
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2017 - 05/2013
7Rhinosinusitis
01/2016 - 04/2008
7Wounds and Injuries (Trauma)
12/2011 - 10/2004
6Hereditary Hemorrhagic Telangiectasia
09/2005 - 03/2002
4Hemorrhage
05/2017 - 03/2002
4Snoring
03/2013 - 01/2005
3Asthma (Bronchial Asthma)
01/2017 - 04/2008
3Allergic Rhinitis
01/2017 - 06/2004
3Keloid
09/2015 - 09/2010
3Ulcer
06/2010 - 10/2004
2Tinnitus
01/2017 - 01/2017
2Taste Disorders (Taste Disorder)
06/2012 - 10/2010
2Dysgeusia (Parageusia)
06/2012 - 10/2010
2Carcinoma (Carcinomatosis)
07/2011 - 08/2003
2Inflammation (Inflammations)
04/2008 - 06/2004
2Epistaxis (Nosebleed)
09/2003 - 03/2002
1Sleep Wake Disorders
11/2021
1Apnea
11/2021
1Dehydration (Water Stress)
05/2021
1Malnutrition (Nutritional Deficiencies)
05/2021
1Aspiration Pneumonia
05/2021
1COVID-19
10/2020
1Rhinitis
10/2020
1Laryngeal Neoplasms (Laryngeal Cancer)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2014 - 07/2002
10Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2003
7Antisense OligonucleotidesIBA
07/2011 - 07/2002
6Pharmaceutical PreparationsIBA
01/2019 - 10/2004
6CytokinesIBA
01/2016 - 02/2004
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 10/2004
5Messenger RNA (mRNA)IBA
07/2011 - 07/2002
4Tyrosine Kinase InhibitorsIBA
05/2017 - 12/2013
4Matrix Metalloproteinases (MMPs)IBA
09/2014 - 03/2005
4Conditioned Culture MediaIBA
07/2011 - 07/2002
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2017 - 12/2013
3TOR Serine-Threonine KinasesIBA
04/2015 - 12/2013
3EverolimusFDA Link
04/2015 - 12/2013
3Sorafenib (BAY 43-9006)FDA Link
04/2015 - 12/2013
3Sunitinib (Sutent)FDA Link
04/2015 - 12/2013
3Platelet-Derived Growth FactorIBA
09/2014 - 01/2009
3Fluorouracil (Carac)FDA LinkGeneric
09/2014 - 05/2013
3Interleukin-6 (Interleukin 6)IBA
09/2014 - 07/2005
3PlatinumIBA
09/2014 - 05/2013
3Interleukin-5 (Interleukin 5)IBA
07/2014 - 07/2008
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2013 - 01/2009
3Estriol (Epiestriol)IBA
09/2005 - 03/2002
2Cisplatin (Platino)FDA LinkGeneric
07/2022 - 07/2004
2nilotinibFDA Link
05/2017 - 06/2016
2Dasatinib (BMS 354825)FDA Link
05/2017 - 06/2016
2Gefitinib (Iressa)FDA Link
05/2017 - 06/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2017 - 06/2016
2Indicators and Reagents (Reagents)IBA
01/2017 - 05/2009
2AllergensIBA
01/2017 - 06/2004
2Immunoglobulin E (IgE)IBA
01/2017 - 06/2004
2EnzymesIBA
06/2016 - 09/2014
2ImmunosorbentsIBA
06/2016 - 09/2014
2Phosphotransferases (Kinase)IBA
04/2015 - 04/2011
2Biomarkers (Surrogate Marker)IBA
09/2014 - 07/2005
2Angiogenic ProteinsIBA
09/2014 - 05/2013
2ErbB Receptors (EGF Receptor)IBA
09/2014 - 07/2002
2Docetaxel (Taxotere)FDA Link
09/2014 - 05/2013
2Carboplatin (JM8)FDA LinkGeneric
04/2011 - 07/2004
2Imatinib Mesylate (Gleevec)FDA Link
04/2011 - 01/2009
2Transforming Growth Factor alpha (TGF-alpha)IBA
06/2010 - 03/2007
2beta CateninIBA
04/2008 - 01/2003
2SuspensionsIBA
05/2006 - 09/2005
2Biological ProductsIBA
07/2005 - 02/2004
2Interleukin-8 (Interleukin 8)IBA
04/2005 - 03/2005
2Collagenases (Collagenase)FDA Link
03/2005 - 10/2004
2Transforming Growth Factor beta (TGF-beta)IBA
02/2005 - 10/2004
2OligonucleotidesIBA
01/2005 - 09/2003
1Oxygen (Dioxygen)IBA
11/2021
1Irritants (Vesicants)IBA
10/2020
1Exonucleases (3' 5' Exonuclease)IBA
01/2019
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2017
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
05/2017
1Cadherins (E-Cadherin)IBA
01/2017
1CateninsIBA
01/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2016
1OligodeoxyribonucleotidesIBA
01/2016
1AmphiregulinIBA
04/2015

Therapy/Procedure

19Therapeutics
01/2019 - 07/2002
5Tonsillectomy
05/2017 - 10/2010
4Continuous Positive Airway Pressure
01/2017 - 05/2006
4Drug Therapy (Chemotherapy)
09/2014 - 07/2004
3Aftercare (After-Treatment)
03/2007 - 03/2002
2Induction Chemotherapy
09/2014 - 05/2013
2Argon Plasma Coagulation
09/2003 - 03/2002
1Long-Term Care
05/2021
1Personal Protective Equipment
10/2020
1Mechanical Ventilators (Ventilator)
10/2020
1Hearing Aids (Hearing Aid)
01/2017
1Cochlear Implantation
01/2017
1Cochlear Implants (Cochlear Implant)
01/2017
1Splints (Splint)
09/2015